{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T13:35:54Z","timestamp":1715780154726},"reference-count":85,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172190"],"award-info":[{"award-number":["82172190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Association for Science and Technology Young Scientific and Technological Talents Support Project","award":["2021-008"],"award-info":[{"award-number":["2021-008"]}]},{"name":"Jiangsu Province \u201c333\u201d High-level Talents Training Project","award":["2022-3-6-146"],"award-info":[{"award-number":["2022-3-6-146"]}]},{"name":"Yangzhou Science and Technology Plan Project","award":["YZ2021148"],"award-info":[{"award-number":["YZ2021148"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX22_2434"],"award-info":[{"award-number":["KYCX22_2434"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Background<\/jats:title>\n               <jats:p>Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator (PIMREG) expression is upregulated in a variety of cancers. However, its potential role in breast cancer (BC) remains uncertain.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were used to gather relevant information. The expression of PIMREG and its clinical implication in BC were assessed by using Wilcoxon rank-sum test. The prognostic value of PIMREG in BC was evaluated through the Cox regression model and nomogram, and visualized by Kaplan-Meier survival curves. Genes\/proteins that interact with PIMREG in BC were also identified through GeneMANIA and MaxLink. Gene set enrichment analysis (GSEA) was then performed. The correlations of the immune cell infiltration and immune checkpoints with the expression of PIMREG in BC were explored via TIMER, TISIDB, and GEPIA. Potential drugs that interact with PIMREG in BC were explored via Q-omic. The siRNA transfection, CCK-8, and transwell migration assay were conducted to explore the function of PIMREG in cell proliferation and migration.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>PIMREG expression was significantly higher in infiltrating ductal carcinoma, estrogen receptor negative BC, and progestin receptor negative BC. High expression of PIMREG was associated with poor overall survival, disease-specific survival, and progression-free interval. A nomogram based on PIMREG was developed with a satisfactory prognostic value. PIMREG also had a high diagnostic ability, with an area under the curve of 0.940. Its correlations with several immunomodulators were also observed. Immune checkpoint CTLA-4 was significantly positively associated with PIMREG. HDAC2 was found as a potentially critical link between PIMREG and BRCA1\/2. In addition, PIMREG knockdown could inhibit cell proliferation and migration in BC.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusions<\/jats:title>\n               <jats:p>The high expression of PIMREG is associated with poor prognosis and immune checkpoints in BC. HDAC2 may be a critical link between PIMREG and BRCA1\/2, potentially a therapeutic target.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.15703","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:13:04Z","timestamp":1689577984000},"page":"e15703","source":"Crossref","is-referenced-by-count":2,"title":["Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation"],"prefix":"10.7717","volume":"11","author":[{"given":"Wenjing","family":"Zhao","sequence":"first","affiliation":[{"name":"Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjin","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangnan College, WuXi, JiangSu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoye","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangnan College, WuXi, JiangSu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangnan College, WuXi, JiangSu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijin","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangnan College, WuXi, JiangSu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyuan","family":"Fu","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The second Affiliated Hospital of Anhui Medical University, Anhui, China"},{"name":"Department of Medicine, AMITA Health Saint Joseph Hospital, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"10.7717\/peerj.15703\/ref-1","doi-asserted-by":"publisher","first-page":"154790","DOI":"10.1016\/j.cyto.2019.154790","article-title":"Silencing of the cytokine receptor TNFRSF13B: a new therapeutic target for triple-negative breast cancer","volume":"125","author":"Abo-Elfadl","year":"2020","journal-title":"Cytokine"},{"key":"10.7717\/peerj.15703\/ref-2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1208\/s12249-022-02212-0","article-title":"The optimized formulation of tamoxifen-loaded niosomes efficiently induced apoptosis and cell cycle arrest in breast cancer cells","volume":"23","author":"Akbarzadeh","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.7717\/peerj.15703\/ref-3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.molonc.2008.08.001","article-title":"The CALM and CALM\/AF10 interactor CATS is a marker for proliferation","volume":"2","author":"Archangelo","year":"2008","journal-title":"Molecular Oncology"},{"key":"10.7717\/peerj.15703\/ref-4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/cco.0000000000000583","article-title":"Window of opportunity trials for biomarker discovery in breast cancer","volume":"31","author":"Arnedos","year":"2019","journal-title":"Current Opinion in Oncology"},{"key":"10.7717\/peerj.15703\/ref-5","doi-asserted-by":"publisher","first-page":"e173\u2013e180","DOI":"10.1016\/s1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"The Lancet Oncology"},{"key":"10.7717\/peerj.15703\/ref-6","doi-asserted-by":"publisher","first-page":"103174","DOI":"10.1016\/j.critrevonc.2020.103174","article-title":"Breast cancer, screening and diagnostic tools: all you need to know","volume":"157","author":"Barba","year":"2021","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.7717\/peerj.15703\/ref-7","doi-asserted-by":"publisher","first-page":"68385","DOI":"10.18632\/oncotarget.11724","article-title":"CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells","volume":"7","author":"Barbutti","year":"2016","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.15703\/ref-8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.7717\/peerj.15703\/ref-9","article-title":"Breast cancer facts & stats","author":"Breastcancer.org","year":"2023"},{"issue":"17","key":"10.7717\/peerj.15703\/ref-10","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.3390\/ijms20174320","article-title":"The Janus face of tumor microenvironment targeted by immunotherapy","volume":"20","author":"Buoncervello","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.15703\/ref-11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/or.2021.8252","article-title":"Inhibition of triple-negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt","volume":"47","author":"Cao","year":"2022","journal-title":"Oncology Reports"},{"key":"10.7717\/peerj.15703\/ref-12","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","article-title":"Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis","volume":"34","author":"Clarke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.7717\/peerj.15703\/ref-13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1210\/me.2005-0063","article-title":"Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells","volume":"20","author":"Cui","year":"2006","journal-title":"Molecular Endocrinology"},{"key":"10.7717\/peerj.15703\/ref-14","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.mcp.2020.101649","article-title":"MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression","volume":"53","author":"Darvishi","year":"2020","journal-title":"Molecular and Cellular Probes"},{"key":"10.7717\/peerj.15703\/ref-15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2326-6066.Cir-16-0237","article-title":"Comprehensive meta-analysis of key immune-related adverse events from CTLA-4 and PD-1\/PD-L1 inhibitors in cancer patients","volume":"5","author":"De\u00a0Velasco","year":"2017","journal-title":"Cancer Immunology Research"},{"key":"10.7717\/peerj.15703\/ref-16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12957-021-02231-4","article-title":"Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA","volume":"19","author":"Ding","year":"2021","journal-title":"World Journal of Surgical Oncology"},{"key":"10.7717\/peerj.15703\/ref-17","doi-asserted-by":"publisher","first-page":"835355","DOI":"10.3389\/fgene.2022.835355","article-title":"Prognostic and diagnostic values of Semaphorin 5B and its correlation with tumor-infiltrating immune cells in kidney renal clear-cell carcinoma","volume":"13","author":"Ding","year":"2022","journal-title":"Frontiers in Genetics"},{"key":"10.7717\/peerj.15703\/ref-18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2015.05.001","article-title":"Biomarkers in breast cancer: where are we and where are we going?","volume":"71","author":"Duffy","year":"2015","journal-title":"Advances in Clinical Chemistry"},{"key":"10.7717\/peerj.15703\/ref-19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1749-6632.2012.06777.x","article-title":"TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes","volume":"1283","author":"El\u00a0Hage","year":"2013","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.7717\/peerj.15703\/ref-20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.21037\/tcr-20-2803","article-title":"Debulking mastectomy with electrochemotherapy: a case report of no surgery approach to recurrent breast cancer","volume":"10","author":"Esposito","year":"2021","journal-title":"Translational Cancer Research"},{"key":"10.7717\/peerj.15703\/ref-21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/med.21364","article-title":"Mitoxantrone, more than just another topoisomerase II poison","volume":"36","author":"Evison","year":"2016","journal-title":"Medicinal Research Reviews"},{"key":"10.7717\/peerj.15703\/ref-22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10585-020-10063-x","article-title":"Electrochemotherapy of skin metastases from breast cancer: a systematic review","volume":"38","author":"Ferioli","year":"2021","journal-title":"Clinical and Experimental Metastasis"},{"key":"10.7717\/peerj.15703\/ref-23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2018.00610","article-title":"Combination immunotherapy: taking cancer vaccines to the next level","volume":"9","author":"Grenier","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.15703\/ref-24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/bioinformatics\/btu344","article-title":"MaxLink: network-based prioritization of genes tightly linked to a disease seed set","volume":"30","author":"Guala","year":"2014","journal-title":"Bioinformatics"},{"key":"10.7717\/peerj.15703\/ref-25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1200\/jco.1991.9.10.1731","article-title":"Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer","volume":"9","author":"Hainsworth","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.7717\/peerj.15703\/ref-26","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2217\/bmm-2019-0085","article-title":"Detection of early breast cancer beyond mammographic screening: a promising biomarker panel","volume":"13","author":"Hamann","year":"2019","journal-title":"Biomarkers in Medicine"},{"key":"10.7717\/peerj.15703\/ref-27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.7717\/peerj.15703\/ref-28","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1111\/jcmm.16416","article-title":"CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma","volume":"25","author":"He","year":"2021","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.7717\/peerj.15703\/ref-29","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.Can-19-2961","article-title":"Proteomic profiling of the ECM of Xenograft breast cancer metastases in different organs reveals distinct metastatic niches","volume":"80","author":"Hebert","year":"2020","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.15703\/ref-30","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/jco.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.7717\/peerj.15703\/ref-31","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.3390\/cancers12113091","article-title":"Analysis of cross-association between mRNA expression and RNAi efficacy for predictive target discovery in colon cancers","volume":"12","author":"Jeong","year":"2020","journal-title":"Cancers"},{"key":"10.7717\/peerj.15703\/ref-32","doi-asserted-by":"publisher","first-page":"e11697","DOI":"10.7717\/peerj.11697","article-title":"High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma","volume":"9","author":"Jiang","year":"2021","journal-title":"PeerJ"},{"key":"10.7717\/peerj.15703\/ref-33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ebiom.2019.04.001","article-title":"Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-\u03baB signaling","volume":"43","author":"Jiang","year":"2019","journal-title":"EBioMedicine"},{"issue":"11","key":"10.7717\/peerj.15703\/ref-34","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/ijms19113445","article-title":"Reactive oxygen species induces lipid droplet accumulation in HepG2 cells by increasing perilipin 2 expression","volume":"19","author":"Jin","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.15703\/ref-35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00005-021-00618-5","article-title":"CTLA-4 expression and its clinical significance in breast cancer","volume":"69","author":"Kern","year":"2021","journal-title":"Archivum Immunologiae et Therapiae Experimentalis (Warsz)"},{"key":"10.7717\/peerj.15703\/ref-36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3892\/ijo.2018.4479","article-title":"Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF-1\u03b1 pathway","volume":"53","author":"Kim","year":"2018","journal-title":"International Journal of Oncology"},{"key":"10.7717\/peerj.15703\/ref-37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.14348\/molcells.2021.0169","article-title":"Q-omics: smart software for assisting oncology and cancer research","volume":"44","author":"Lee","year":"2021","journal-title":"Molecular Cell"},{"key":"10.7717\/peerj.15703\/ref-38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biology"},{"key":"10.7717\/peerj.15703\/ref-39","doi-asserted-by":"publisher","first-page":"e108\u2013e110","DOI":"10.1158\/0008-5472.Can-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.15703\/ref-40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40291-018-0344-x","article-title":"Association between CHEK2*1100delC and breast cancer: a systematic review and meta-analysis","volume":"22","author":"Liang","year":"2018","journal-title":"Molecular Diagnosis & Therapy"},{"key":"10.7717\/peerj.15703\/ref-41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.7717\/peerj.15703\/ref-42","doi-asserted-by":"publisher","first-page":"602160","DOI":"10.3389\/fgene.2021.602160","article-title":"ERBB1\/2\/3 expression, prognosis, and immune infiltration in cutaneous melanoma","volume":"12","author":"Liu","year":"2021","journal-title":"Frontiers in Genetics"},{"key":"10.7717\/peerj.15703\/ref-43","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.omtn.2021.03.014","article-title":"ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma","volume":"24","author":"Lou","year":"2021","journal-title":"Molecular Therapy\u2014Nucleic Acids"},{"key":"10.7717\/peerj.15703\/ref-44","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3892\/mmr.2012.999","article-title":"The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo","volume":"6","author":"Ma","year":"2012","journal-title":"Molecular Medicine Reports"},{"key":"10.7717\/peerj.15703\/ref-45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00726-008-0137-3","article-title":"Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2, 3-dioxygenase (IDO), a novel target in cancer disease","volume":"37","author":"Macchiarulo","year":"2009","journal-title":"Amino Acids"},{"key":"10.7717\/peerj.15703\/ref-46","doi-asserted-by":"publisher","first-page":"109795","DOI":"10.1016\/j.cbi.2021.109795","article-title":"Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells","volume":"352","author":"Markowicz-Piasecka","year":"2022","journal-title":"Chemico-Biological Interactions"},{"key":"10.7717\/peerj.15703\/ref-47","doi-asserted-by":"publisher","first-page":"h6576","DOI":"10.1136\/bmj.h6576","article-title":"Screening for early breast cancer reduces invasive cancer, study finds","volume":"351","author":"Mayor","year":"2015","journal-title":"Bmj"},{"key":"10.7717\/peerj.15703\/ref-48","doi-asserted-by":"publisher","first-page":"643771","DOI":"10.3389\/fimmu.2021.643771","article-title":"Macrophage biology and mechanisms of immune suppression in breast cancer","volume":"12","author":"Mehta","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.15703\/ref-49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","article-title":"The extracellular matrix: tools and insights for the omics era","volume":"49","author":"Naba","year":"2016","journal-title":"Matrix Biology"},{"key":"10.7717\/peerj.15703\/ref-50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5114\/pm.2019.86833","article-title":"Prognostic factors influencing prognosis in early breast cancer patients","volume":"18","author":"Najafi","year":"2019","journal-title":"Prz Menopauzalny"},{"key":"10.7717\/peerj.15703\/ref-51","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1200\/jco.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.7717\/peerj.15703\/ref-52","doi-asserted-by":"publisher","first-page":"e1629780","DOI":"10.1080\/2162402x.2019.1629780","article-title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","volume":"8","author":"Noblejas-L\u00f3pez","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.7717\/peerj.15703\/ref-53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fimmu.2018.00070","article-title":"Tissue-dependent tumor microenvironments and their impact on immunotherapy responses","volume":"9","author":"Oliver","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.15703\/ref-54","doi-asserted-by":"publisher","first-page":"83308","DOI":"10.18632\/oncotarget.13088","article-title":"Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.15703\/ref-55","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2796.2011.02427.x","article-title":"The human protein atlas as a proteomic resource for biomarker discovery","volume":"270","author":"Pont\u00e9n","year":"2011","journal-title":"Journal of Internal Medicine"},{"key":"10.7717\/peerj.15703\/ref-56","doi-asserted-by":"publisher","first-page":"e943\u2013e953","DOI":"10.1002\/onco.13734","article-title":"Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer","volume":"26","author":"Pramod","year":"2021","journal-title":"Oncologist"},{"key":"10.7717\/peerj.15703\/ref-57","doi-asserted-by":"publisher","first-page":"729340","DOI":"10.3389\/fonc.2021.729340","article-title":"Tumor mutation burden-associated LINC00638\/miR-4732-3p\/ULBP1 axis promotes immune escape via PD-L1 in hepatocellular carcinoma","volume":"11","author":"Qi","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.15703\/ref-58","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"10.7717\/peerj.15703\/ref-59","first-page":"71","article-title":"An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat Bioinforma Biomath"},{"key":"10.7717\/peerj.15703\/ref-60","doi-asserted-by":"publisher","first-page":"105493","DOI":"10.1016\/j.ejps.2020.105493","article-title":"Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-\u03baB activation, and decrease TNF-alpha secretion in primary microglia","volume":"154","author":"Rinne","year":"2020","journal-title":"European Journal of Pharmaceutical Science"},{"key":"10.7717\/peerj.15703\/ref-61","doi-asserted-by":"publisher","first-page":"772144","DOI":"10.3389\/fonc.2021.772144","article-title":"The role of electrochemotherapy in the cutaneous and subcutaneous metastases from breast cancer: analysis of predictive factors to treatment from an Italian cohort of patients","volume":"11","author":"Russano","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.15703\/ref-62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/or.2019.7435","article-title":"Autologous dendritic cells and activated cytotoxic T-cells as combination therapy for breast cancer","volume":"43","author":"Shevchenko","year":"2020","journal-title":"Oncology Reports"},{"key":"10.7717\/peerj.15703\/ref-63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.15703\/ref-64","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1158\/1535-7163.Mct-19-0495","article-title":"Combination immunotherapy with cytotoxic T-lymphocyte-associated antigen-4 and programmed death protein-1 inhibitors prevents postoperative breast tumor recurrence and metastasis","volume":"19","author":"Sun","year":"2020","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.7717\/peerj.15703\/ref-65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.15703\/ref-66","doi-asserted-by":"publisher","first-page":"e2024","DOI":"10.1371\/journal.pone.0002024","article-title":"BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history","volume":"3","author":"Toh","year":"2008","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.15703\/ref-67","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.18632\/oncotarget.3638","article-title":"YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network","volume":"6","author":"V\u00e9quaud","year":"2015","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.15703\/ref-68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/bioinformatics\/btu671","article-title":"Novel function discovery with GeneMANIA: a new integrated resource for gene function prediction in Escherichia coli","volume":"31","author":"Vlasblom","year":"2015","journal-title":"Bioinformatics"},{"key":"10.7717\/peerj.15703\/ref-69","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/1568009620666200619123725","article-title":"The roles of alternative splicing in tumor-immune cell interactions","volume":"20","author":"Wang","year":"2020","journal-title":"Current Cancer Drug Targets"},{"key":"10.7717\/peerj.15703\/ref-70","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1039\/d1bm01409a","article-title":"Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against immune cold cancer","volume":"9","author":"Wu","year":"2021","journal-title":"Biomaterials Science"},{"key":"10.7717\/peerj.15703\/ref-71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2022.09.001","article-title":"Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway","volume":"191","author":"Xie","year":"2022","journal-title":"Free Radical Biology and Medicine"},{"key":"10.7717\/peerj.15703\/ref-72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","article-title":"Immune checkpoint therapy in liver cancer","volume":"37","author":"Xu","year":"2018","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.15703\/ref-73","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/cam4.3907","article-title":"MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer","volume":"10","author":"Xu","year":"2021","journal-title":"Cancer Medicine"},{"key":"10.7717\/peerj.15703\/ref-74","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1111\/cas.13722","article-title":"Regulation of antitumor miR-144-5p targets oncogenes: direct regulation of syndecan-3 and its clinical significance","volume":"109","author":"Yamada","year":"2018","journal-title":"Cancer Science"},{"issue":"10","key":"10.7717\/peerj.15703\/ref-75","doi-asserted-by":"publisher","first-page":"e002875","DOI":"10.1136\/jitc-2021-002875","article-title":"Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis","volume":"9","author":"Yang","year":"2021","journal-title":"The Journal for ImmunoTherapy of Cancer"},{"key":"10.7717\/peerj.15703\/ref-76","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12282-019-00991-2","article-title":"Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells","volume":"26","author":"Yao","year":"2019","journal-title":"Breast Cancer"},{"key":"10.7717\/peerj.15703\/ref-77","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"10.7717\/peerj.15703\/ref-78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.15703\/ref-79","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbrc.2019.03.207","article-title":"Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.7717\/peerj.15703\/ref-80","doi-asserted-by":"publisher","first-page":"13415","DOI":"10.1073\/pnas.0709227105","article-title":"RCS1, a substrate of APC\/C, controls the metaphase to anaphase transition","volume":"105","author":"Zhao","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.15703\/ref-81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/bcpt.13481","article-title":"Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer","volume":"128","author":"Zhong","year":"2021","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.7717\/peerj.15703\/ref-82","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fcell.2020.00629","article-title":"A novel ten-gene signature predicting prognosis in hepatocellular carcinoma","volume":"8","author":"Zhou","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.7717\/peerj.15703\/ref-83","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41419-021-03933-z","article-title":"FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer","volume":"12","author":"Zhou","year":"2021","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.15703\/ref-84","doi-asserted-by":"publisher","first-page":"6419695","DOI":"10.1155\/2022\/6419695","article-title":"The hypoxia-related gene COL5A1 is a prognostic and immunological biomarker for multiple human tumors","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.7717\/peerj.15703\/ref-85","doi-asserted-by":"publisher","first-page":"687778","DOI":"10.3389\/fgene.2021.687778","article-title":"Pan-cancer analysis of PIMREG as a biomarker for the prognostic and immunological role","volume":"12","author":"Zhu","year":"2021","journal-title":"Frontiers in Genetics"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/15703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15703.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15703.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:13:24Z","timestamp":1689578004000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/15703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":85,"alternative-id":["10.7717\/peerj.15703"],"URL":"https:\/\/doi.org\/10.7717\/peerj.15703","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"article-number":"e15703"}}